Larson Tina Marriott's Form 4 filing
Recursion Pharmaceuticals, Inc. (RXRX) · filed Oct 3, 2022
- Accession no.
- 0001209191-22-051979
- Filed
- Oct 3, 2022
- Trade date
- Sep 29, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $173.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Larson Tina MarriottCIK 0001856414 | Officer (President and COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2022 | Class A Common Stock | MOption exerciseAcquired | +16,000 | $1.06 | +$16,960 | 221,107 | Direct | |
| Sep 29, 2022 | Class A Common Stock | SSaleDisposed | −15,936 | $10.86 | −$173,064.96 | 205,171 | Direct | |
| Sep 29, 2022 | Class A Common Stock | SSaleDisposed | −64 | $11.53 | −$737.92 | 205,107 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2022 | Class A Common Stock | MOption exerciseDisposed | −16,000 | $0.00 | $0 | 602,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.